Products

Our products

Learn more about our product portfolio and how we’re prioritizing vaccines and specialty medicines to get ahead of disease together.

Our product areas Products A-Z

Woman opening a lab machine in protective gear

Close Video

Scroll to explore

Our product areas

Our portfolio spans three product areas: vaccines, specialty and general medicines. We’re prioritizing R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.

Specialty medicines

Specialty medicines are prescribed by specialist healthcare practitioners. Our portfolio of specialty medicines prevents and treats diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer.

Vaccines

Our portfolio of more than 20 marketed vaccines is one of the broadest in the industry. We deliver more than 1 million doses of our vaccines every day. Our vaccines portfolio targets infectious diseases from birth throughout adulthood.

General medicines

General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. General medicines include inhalers for asthma and COPD to antibiotics. Every day, our general medicines make life better for millions of people all over the world.

Industry support

Drug Shortages Canada allows you to search a database of drug shortages and discontinuations.

Visit Drug Shortages Canada

We are proud to support the Medications and Sharps Return Programs of the Health Products Stewardship Association (HPSA). This initiative provides patients with safe and convenient methods to dispose health products in an environmentally responsible way.

Health Products Stewardship Association

Continue to Products A-Z

Products

Our products

Our product areas

Specialty medicines

Vaccines

General medicines

Industry support

Drug Shortages Canada

Health Products Stewardship Association

You might also like

Report a possible side effect

Innovation

Responsibility